IGOR BILINSKY
CIK 1594604 · Chief Operating Officer · last filed 2026-06-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$562.6K
Companies
5
Total Filings
50
Lifetime Open-Market Net
$105.5K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| IOVA | Chief Operating Officer | 137,896 | $4.08 | $562.6K | $0 | 30 | 2026-06-09 |
| Oncternal Therapeutics, Inc. (ONCT) Delisted | Chief Business Officer | — | $0.53 | — | $0 | 5 | 2021-02-16 |
| Armata Pharmaceuticals, Inc. (APHB) Delisted | Chief Operating Officer | — | — | — | $0 | 3 | 2017-06-01 |
| Ignyta, Inc. (RXDX) Delisted | GM, Immuno-Oncology/SVP Sp Ops | 6,960 | $199.92 | $1.39M | $0 | 2 | 2016-01-11 |
| Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Sr VP, Corporate Development | 193,798 | — | — | $105.5K | 10 | 2015-07-15 |
Recent Filings · Page 5 of 5
50 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2015-07-15 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Sell (S) | −1,258 | -$879 | EDGAR |
| 2015-04-15 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Sell (S) | −1,257 | -$1.2K | EDGAR |
| 2015-01-21 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Grant (A) | +70,000 | $700 | EDGAR |
| 2015-01-14 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Sell (S) | −1,335 | -$1.5K | EDGAR |
| 2014-10-14 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Sell (S) | −1,335 | -$1.4K | EDGAR |
| 2014-08-27 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Sell (S) | −12,500 | -$15.7K | EDGAR |
| 2014-07-15 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Sell (S) | −1,335 | -$1.6K | EDGAR |
| 2014-01-15 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Grant (A) | +90,000 | $900 | EDGAR |
| 2014-01-14 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Mixed | +88,276 | $125.4K | EDGAR |
| 2014-01-08 | Fresh Tracks Therapeutics, Inc. (VICL) Delisted | Tax (F) | −54 | -$71 | EDGAR |
Showing 41–50 of 50
Prev
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.